Why It Matters
Thomas Jefferson University confronts an existential crisis as federal policies threaten its core missions. Proposed NIH cuts of 40 percent and new 15 percent caps on indirect costs directly jeopardize research infrastructure. The elimination of Graduate PLUS loans threatens medical school affordability precisely as federal policy demands expanded physician training to address an 86,000-doctor shortage by 2036.
The administration is investigating universities on diversity policies and threatening to condition federal funding on institutional changes. Without sustained federal advocacy, Thomas Jefferson risks losing research competitiveness, enrollment capacity, and institutional autonomy. The university’s $60,000 quarterly investment with Squire Patton Boggs signals a strategic decision to fight for survival in a fundamentally changed federal landscape.
By the Numbers
Thomas Jefferson University paid Squire Patton Boggs $60,000 in the fourth quarterfor federal advocacy services. This represents the latest installment in a two-decade lobbying relationship dating to 2003, during which the university has filed 147 total disclosures and spent $6.165 million on federal advocacy.
The university employs a multi-firm strategy with three active lobbying partners. Squire Patton Boggs leads with 37 disclosures and $2.16 million since 2017, followed by Cornerstone Government Affairs Inc. (31 disclosures, $1.8 million since 2018) and Cozen O’Connor Public Strategies LLC (36 disclosures, $1 million+ since 2011).
The Agenda
Thomas Jefferson University is lobbying on issues central to its mission as an academic medical center. Historical priorities include securing federal research funding from the National Institutes of Health, shaping Medicare and Medicaid policy, advancing graduate medical education financing, and influencing Higher Education Act reauthorization.
This quarter’s engagement occurs amid significant congressional activity. The Expanding Medical Education Act and Health Care Workforce Expansion Act of 2025 propose federal grants for medical school expansion in underserved areas. The RESEARCHER Act addresses financial stability for graduate researchers.
The university faces defensive lobbying pressures from proposed National Institutes of Health funding cuts and changes to federal student loan programs. Recent congressional hearings on antisemitism in higher education and diversity initiatives signal heightened federal scrutiny.
Broader Context
The NIH has frozen or terminated nearly 2,500 grants, with proposed cuts potentially reaching 40 percent of the agency’s budget. The administration has capped indirect cost recovery at 15 percent—down from typical rates of 50-70 percent—threatening research infrastructure.
Student financing faces parallel disruption. The administration has proposed eliminating Graduate PLUS loans entirely, which roughly half of medical students use, just as the AAMC projects a shortfall of up to 86,000 physicians by 2036.
The Trump administration launched investigations into 52 universities regarding diversity policies, with the Department of Education threatening federal funding as leverage for policy changes.
Between The Lines
Congress is reshaping academic medicine through competing legislative efforts. Multiple bills address physician workforce shortages, while the legislative environment remains hostile to research funding. Rep. Mike Levin, Rep. Morgan McGarvey, and Senator Kirsten Gillibrand have publicly warned about proposed NIH cuts.
Congressional hearings on Antisemitism in Higher Education and Diversity, Equity, and Inclusion initiatives signal that federal funding could become entangled with institutional policies on campus governance.
Competitive Landscape
Thomas Jefferson operates within an intensely competitive lobbying environment as universities nationwide escalate federal advocacy. Washington State University is lobbying on Pell Grants and NIH funding. Texas A&M University System advocates on college cost reduction and nursing workforce development.
This collective activity demonstrates that securing federal research funding represents a top institutional priority across higher education. Academic medical centers must maintain sophisticated lobbying operations to compete effectively for limited federal resources.
The Bottom Line
Thomas Jefferson University’s continued engagement with Squire Patton Boggs reflects an institution defending core interests amid severe federal headwinds. The university faces direct threats from proposed NIH funding cuts, elimination of graduate student loans, and federal pressure on institutional autonomy. The $60,000 quarterly payment signals that sustained, professional advocacy has become essential for academic medical centers navigating an unstable federal environment.
Access the Legis1 platform for comprehensive political news, data, and insights.
Spot something wrong? Report an issue with this article